[Controlled double-blind clinical study of a new rhinologic preparation with mucolytic-anti-inflammatory action].
D000111:Acetylcysteine / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001548:Benzalkonium Compounds / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D005438:Fludrocortisone / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009668:Nose Diseases / Q000188:drug therapy*; D013566:Sympathomimetics / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D001548:Benzalkonium Compounds; D013566:Sympathomimetics; D005438:Fludrocortisone; D000111:Acetylcysteine
Studio clinico controllato doppio-cieco di un nuovo preparato rinologico ad azione mucolitico-antiflogistica.